152 related articles for article (PubMed ID: 30864163)
1. Flip-flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis.
Shahrabi S; Zayeri ZD; Ansari N; Hadad EH; Rajaei E
J Cell Physiol; 2019 Aug; 234(10):16998-17010. PubMed ID: 30864163
[TBL] [Abstract][Full Text] [Related]
2. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
3. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
[TBL] [Abstract][Full Text] [Related]
4. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Natural Killer Cells Proliferation by Cytokine Stimulation.
Pencheva-Demireva M; El-Darawish Y; Kavaldzhieva K; Mladenov N; Lazarov V; Dimitrova-Dikanarova D; Markova T; Nikolov R; Okamura H
Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):85-88. PubMed ID: 31009333
[TBL] [Abstract][Full Text] [Related]
6. NK cell subsets in autoimmune diseases.
Zhang C; Tian Z
J Autoimmun; 2017 Sep; 83():22-30. PubMed ID: 28285736
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
8. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
[TBL] [Abstract][Full Text] [Related]
9. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
10. The role of natural killer cells in autoimmune liver disease: a comprehensive review.
Hudspeth K; Pontarini E; Tentorio P; Cimino M; Donadon M; Torzilli G; Lugli E; Della Bella S; Gershwin ME; Mavilio D
J Autoimmun; 2013 Oct; 46():55-65. PubMed ID: 23880068
[TBL] [Abstract][Full Text] [Related]
11. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
Smits NC; Coupet TA; Godbersen C; Sentman CL
Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
[TBL] [Abstract][Full Text] [Related]
12. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
13. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
14. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
[TBL] [Abstract][Full Text] [Related]
15. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
Tietje A; Li J; Yu X; Wei Y
Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784
[TBL] [Abstract][Full Text] [Related]
16. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
[TBL] [Abstract][Full Text] [Related]
17. Activating and inhibitory receptors of natural killer cells.
Pegram HJ; Andrews DM; Smyth MJ; Darcy PK; Kershaw MH
Immunol Cell Biol; 2011 Feb; 89(2):216-24. PubMed ID: 20567250
[TBL] [Abstract][Full Text] [Related]
18. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
Törnroos H; Hägerstrand H; Lindqvist C
Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
[TBL] [Abstract][Full Text] [Related]
20. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
